Technology

CureVac does not rule out faster approval of COVID-19 vaccine by Reuters

© Reuters. PHILO PHOTO: Employees Philipp Hoffmann, from the German biopharmaceutical company CureVac, demonstrate research workflow on a vaccine for coronavirus (COVID-19) at a laboratory in Tübingen FRANKFURT (Reuters) – German biotechnology company CureVac does not rule out a speedy approval process for its prospective vaccine against COVID-19, its chief …

Read More »

A Wall Street chief strategist says he is considering buying dirty cheap ‘powerful microcap’ shares, which have done even better than their big-cap peers since the coronavirus crash

Michael Nagle / Xinhua / Getty Images Microcap shares perform just as well as some investors’ favorite, but at much cheaper ratings, James Paulsen, chief investment strategist at The Leuthold Group, noted in a note. The “powerful microcaps” outperformed their tech peers and even the S&P 500’s Growth Index, despite …

Read More »